NASDAQ:SYBX

Synlogic Stock Predictions

Healthcare > Biotechnology

Buy SYBX

*Your capital is at risk

$1.20

+0.0500 (+4.35%)

At Close: Jul 31, 2026

Currently predicting for Mon, 3 Aug 2026

SYBX Live board

Community Bull/Bear

Target Next close

Join the SYBX prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

SYBX Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For SYBX

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

SYBX Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	USD target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT SYNLOGIC INC

Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase II clinical trials to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
FOX $50.81	2.22%	Jul 27
UNFI $49.05	3.63%	Jul 27
BIIB $202.19	0.376%	Jul 24
TSCO $30.32	1.48%	Jul 23
S SW $43.71	5.17%	Jul 23

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by